Why Exact Sciences Shares Are Rallying 13.8% in 2018

A decision by the American Cancer Society in May to drop the minimum age to recommend colon cancer screening to 45 years from 50 has helped propel Exact Sciences(NASDAQ:EXAS) shares 13.8% higher in 2018, according to S&P Global Market Intelligence.